Skip to Main Content

Paper Details

Correction to: Selinexor in combination with topotecan in patients with advanced or metastatic solid tumors: Results of an open-label, single-center, multi-arm phase Ib study.
Invest New Drugs
1
2022
Selinexor, advanced or metastatic solid tumors, patients, topotecan
Author NameAffiliation
Rivka R ColenThe University of Texas MD Anderson Cancer Center
Shubham PantDepartment of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center
Funda Meric-BernstamDepartment of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center
  • 1 - 3

Datasets

Release 1.2